Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Other Non-Current Liabilities: 2014-2025

Historic Other Non-Current Liabilities for BIO-TECHNE (TECH) over the last 11 years, with Sep 2025 value amounting to $23.8 million.

  • BIO-TECHNE's Other Non-Current Liabilities rose 20.34% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.8 million, marking a year-over-year increase of 20.34%. This contributed to the annual value of $27.1 million for FY2025, which is 105.84% up from last year.
  • BIO-TECHNE's Other Non-Current Liabilities amounted to $23.8 million in Q3 2025, which was down 12.07% from $27.1 million recorded in Q2 2025.
  • In the past 5 years, BIO-TECHNE's Other Non-Current Liabilities ranged from a high of $27.1 million in Q2 2025 and a low of $9.4 million during Q3 2023.
  • Its 3-year average for Other Non-Current Liabilities is $15.5 million, with a median of $13.2 million in 2024.
  • In the last 5 years, BIO-TECHNE's Other Non-Current Liabilities slumped by 54.46% in 2021 and then skyrocketed by 110.66% in 2024.
  • BIO-TECHNE's Other Non-Current Liabilities (Quarterly) stood at $11.7 million in 2021, then fell by 3.50% to $11.3 million in 2022, then spiked by 53.15% to $17.4 million in 2023, then tumbled by 34.70% to $11.3 million in 2024, then grew by 20.34% to $23.8 million in 2025.
  • Its Other Non-Current Liabilities was $23.8 million in Q3 2025, compared to $27.1 million in Q2 2025 and $15.7 million in Q1 2025.